MIBG Scintigraphy and Arrhythmic Risk in Myocarditis

Area of Science:

• Cardiology
• Medical Imaging
• Nuclear Medicine

Background:

• Cardiac magnetic resonance imaging (MRI) frequently identifies myocardial fibrosis post-myocarditis.
• Myocardial fibrosis is linked to arrhythmias in various heart conditions.
• MIBG scintigraphy assesses cardiac sympathetic innervation, used in heart failure and defibrillator candidate evaluations.

Purpose of the Study:

• To evaluate the arrhythmogenic risk associated with non-ischemic scars detected by cardiac MRI using MIBG scintigraphy.
• To assess this risk in both symptomatic and asymptomatic patients with a history consistent with myocarditis.

Main Methods:

• Retrospective selection of 50 patients with non-ischemic myocardial fibrosis on cardiac MRI.
• Patients underwent tomographic MIBG scintigraphy at least 6 months post-event.
• Cardiac MRI parameters (volumes, ejection fraction, T1/T2 mapping, LGE) and clinical data were analyzed.

Main Results:

• Most patients (n=50) showed normal ventricular volumes and ejection fractions on MRI.
• Only one patient had a positive MIBG scan, correlating with severe clinical presentation (PVBs, PSVT) and MRI findings (LV dysfunction, midwall LGE).
• Incidental non-ischemic LGE was common, but MIBG was largely negative, suggesting low independent arrhythmic risk.

Conclusions:

• MIBG scintigraphy appears valuable for assessing arrhythmic risk in post-myocarditis patients.
• It may help mitigate concerns over incidental non-ischemic LGE findings on cardiac MRI.
• The study suggests non-ischemic LGE alone may not independently confer a high arrhythmic risk.